• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估胃癌风险:病理学家的新工具

Assessing risks for gastric cancer: new tools for pathologists.

作者信息

Genta Robert M, Rugge Massimo

机构信息

Pathology and Laboratory Service-113, VA North Texas Health Care System, 4500 S. Lancaster Road, Dallas, TX 75216, USA.

出版信息

World J Gastroenterol. 2006 Sep 21;12(35):5622-7. doi: 10.3748/wjg.v12.i35.5622.

DOI:10.3748/wjg.v12.i35.5622
PMID:17007013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4088161/
Abstract

Although the Sydney Systems (original and updated) for the classification of gastritis have contributed substantially to the uniformity of the reporting of gastric conditions, they lack immediacy in conveying to the user information about gastric cancer risk. In this review, we summarize the current understanding of the gastric lesions associated with an increased risk for cancer, and present the rationale for a proposal for new ways of reporting gastritis. In addition to the traditional histopathological data gathered and evaluated according to the Sydney System rules, pathologists could add an assessment expressed as grading and staging of the gastric inflammatory and atrophic lesions and integrate these findings with pertinent laboratory information on pepsinogens and gastrin levels. Such an integrated report could facilitate clinicians' approach to the management of patients with gastric conditions.

摘要

尽管悉尼胃炎分类系统(原始版和更新版)对胃部疾病报告的一致性做出了重大贡献,但它们在向使用者传达胃癌风险信息方面缺乏即时性。在本综述中,我们总结了目前对与癌症风险增加相关的胃部病变的认识,并提出了关于胃炎新报告方式的建议依据。除了按照悉尼系统规则收集和评估的传统组织病理学数据外,病理学家还可以增加一项以胃炎性和萎缩性病变的分级和分期表示的评估,并将这些结果与有关胃蛋白酶原和胃泌素水平的相关实验室信息相结合。这样一份综合报告可以促进临床医生对胃部疾病患者的管理。

相似文献

1
Assessing risks for gastric cancer: new tools for pathologists.评估胃癌风险:病理学家的新工具
World J Gastroenterol. 2006 Sep 21;12(35):5622-7. doi: 10.3748/wjg.v12.i35.5622.
2
Staging and grading of chronic gastritis.慢性胃炎的分期与分级
Hum Pathol. 2005 Mar;36(3):228-33. doi: 10.1016/j.humpath.2004.12.008.
3
The effect of incisura angularis biopsy sampling on the assessment of gastritis stage.角切迹活检取材对胃炎分期评估的影响
Eur J Gastroenterol Hepatol. 2014 May;26(5):510-3. doi: 10.1097/MEG.0000000000000082.
4
Review article: Gastric atrophy and atrophic gastritis--nebulous concepts in search of a definition.综述文章:胃萎缩与萎缩性胃炎——寻求定义的模糊概念
Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:17-23. doi: 10.1111/j.1365-2036.1998.00003.x.
5
[Morphological criteria of the risk of stomach cancer in gastritis patients].[胃炎患者胃癌风险的形态学标准]
Vopr Onkol. 1987;33(9):38-42.
6
Association between gastric cancer and the Kyoto classification of gastritis.胃癌与京都胃炎分类之间的关联。
J Gastroenterol Hepatol. 2017 Sep;32(9):1581-1586. doi: 10.1111/jgh.13764.
7
OLGA staging for gastritis: a tutorial.用于胃炎的OLGA分期:教程
Dig Liver Dis. 2008 Aug;40(8):650-8. doi: 10.1016/j.dld.2008.02.030.
8
Chronic gastritis classifications.慢性胃炎的分类。
Tunis Med. 2018 Jul;96(7):405-410.
9
Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.角部活检对胃肿瘤前病变检测及胃癌风险评估的影响。
J Clin Pathol. 2016 Jan;69(1):19-25. doi: 10.1136/jclinpath-2015-202858. Epub 2015 Jul 10.
10
Gastritis and its relation to gastric carcinogenesis.胃炎及其与胃癌发生的关系。
Semin Diagn Pathol. 1991 Aug;8(3):137-48.

引用本文的文献

1
Patterns of sialyl-Lewis X expression predict gastric histopathology.唾液酸化路易斯X的表达模式可预测胃组织病理学。
Diagn Pathol. 2025 Jun 23;20(1):76. doi: 10.1186/s13000-025-01673-8.
2
Histopathological Evaluation of Gastric Mucosal Atrophy for Predicting Gastric Cancer Risk: Problems and Solutions.用于预测胃癌风险的胃黏膜萎缩的组织病理学评估:问题与解决方案
Diagnostics (Basel). 2023 Jul 26;13(15):2478. doi: 10.3390/diagnostics13152478.
3
A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area.一项用于在中危胃癌地区早期检测肿瘤性胃部病变的 DSC 测试。
Int J Mol Sci. 2023 Feb 7;24(4):3290. doi: 10.3390/ijms24043290.
4
Clinical outcomes of no residual disease in the specimen after endoscopic resection for gastric neoplasms.胃肿瘤内镜切除术后标本无残留病灶的临床结局
Surg Endosc. 2016 Feb;30(2):610-618. doi: 10.1007/s00464-015-4248-0. Epub 2015 Jun 20.
5
Association of Helicobacter pylori and iNOS production by macrophages and lymphocytes in the gastric mucosa in chronic gastritis.慢性胃炎胃黏膜中巨噬细胞和淋巴细胞产生的幽门螺杆菌与诱导型一氧化氮合酶的关系。
J Immunol Res. 2014;2014:762514. doi: 10.1155/2014/762514. Epub 2014 Sep 18.
6
Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.基质金属蛋白酶 2、14、24 和 25 的表达及其组织抑制剂 3 作为晚期人类胃癌潜在的分子标志物。
Dis Markers. 2014;2014:285906. doi: 10.1155/2014/285906. Epub 2014 Feb 11.
7
Secondary prevention of gastric cancer.胃癌的二级预防
Gut. 2007 Dec;56(12):1646-7. doi: 10.1136/gut.2007.133926.

本文引用的文献

1
Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.血清胃蛋白酶原I和II、胃泌素-17及抗幽门螺杆菌抗体在基层医疗中消化不良患者管理中的临床应用价值
Dig Liver Dis. 2005 Jul;37(7):501-8. doi: 10.1016/j.dld.2005.01.016. Epub 2005 Apr 18.
2
Staging and grading of chronic gastritis.慢性胃炎的分期与分级
Hum Pathol. 2005 Mar;36(3):228-33. doi: 10.1016/j.humpath.2004.12.008.
3
The biological model of gastric carcinogenesis.胃癌发生的生物学模型。
IARC Sci Publ. 2004(157):301-10.
4
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection.幽门螺杆菌感染所致胃癌患者一级亲属的“血清学活检”
Scand J Gastroenterol. 2003 Dec;38(12):1223-7. doi: 10.1080/00365520310007044.
5
The long term outcome of gastric non-invasive neoplasia.胃非侵袭性肿瘤的长期转归
Gut. 2003 Aug;52(8):1111-6. doi: 10.1136/gut.52.8.1111.
6
The serological gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient: significance for primary care based on a survey of the literature.
Scand J Gastroenterol Suppl. 2002(236):22-6. doi: 10.1080/003655202320621418.
7
Diagnosis of atrophic gastritis from a serum sample.通过血清样本诊断萎缩性胃炎。
Clin Lab. 2002;48(9-10):505-15.
8
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.胃黏膜萎缩:采用新的分类和分级标准时观察者间的一致性
Aliment Pharmacol Ther. 2002 Jul;16(7):1249-59. doi: 10.1046/j.1365-2036.2002.01301.x.
9
Review article: intestinal metaplasia and gastric carcinogenesis.综述文章:肠化生与胃癌发生
Aliment Pharmacol Ther. 2002 Jul;16(7):1209-16. doi: 10.1046/j.1365-2036.2002.01300.x.
10
Diagnosis of gastritis by means of a combination of serological analyses.
Clin Chim Acta. 2002 Jun;320(1-2):17-27. doi: 10.1016/s0009-8981(02)00040-2.